首页> 外文OA文献 >The preparation of lanthanide macrocyclic complexes for use as MRI and luminescence contrast agents
【2h】

The preparation of lanthanide macrocyclic complexes for use as MRI and luminescence contrast agents

机译:镧系大环配合物的制备,用作MRI和发光造影剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multimodality imaging agents have the potential to be detected in both MRI and optical imaging experiments allowing for visualisation of biological systems from the cellular level up to the whole body. Lanthanide complexes have shown great promise as components of compounds that can act as either MRI contrast agents or luminescent imaging agents dependent on the metal centre incorporated (e.g. gadolinium(III) or europium(III)/terbium(III)respectively).This thesis describes the design, synthesis and characterisation of multimodality lanthanide imaging agents. The synthesis of a series of lanthanide chelators based on DO3A bearing a benzimidazole or a benzyl derivative that can act as both a chromophore unit and a linking group for conjugation that has the functionality to couple to an optical dye (either rhodamine or BODIPY derivatives) is discussed.A series of lanthanide complexes with either a nitro- or amino-benzyl benzimidazole DO3A chelator or with an aminobenzyl DO3A chelator have been prepared. A number of strategies have been attempted to couple the complexes to an optical dye to form a multimodality imaging agent.Physical properties and cellular uptake of the lanthanide complexes have been investigated. It was shown that the benzimidazole ligands can sensitise the luminescence of both the europium(III) and terbium(III) metal ions. Relaxation rates of the gadolinium(III) benzimidazole DOS A complexes are comparable to that of commercial contrast agents. The relaxivity of the gadolinium(III) complex formed with the ligand l,4,7-tris(carboxymethyl)-10-(l-(4-nitrobenzyl)-2-methyl benzimidazole)-1,4,7,10-tetraazacyclododecane (34) is 6.22 mM"1 s" 1 , with the relaxivity of the gadolinium(III) complex formed with 1,4,7-tris(carboxymethyl)-10-( 1 -(4-aminobenzyl)-2-methyl benzimidazole)-1,4,7,10-tetraazacyclododecane (37) was found to be lower at 4.51 mM"1 s" 1 . The luminescence lifetimes of the europium(III) and terbium(III) complexes in and D2O were used to calculate the number of coordinated water molecules in aqueous solution [q = 1.19 for the europium(III) complex of (34), 0.7-0.8 for the europium(III) complex of (37) and 1.25 for the terbium(III) complexes of (34)]
机译:多模态成像剂具有在MRI和光学成像实验中被检测到的潜力,从而可以实现从细胞水平到整个人体的生物系统的可视化。镧系元素络合物作为可作为MRI造影剂或发光成像剂的化合物的成分显示出广阔的前景,这些化合物取决于所结合的金属中心(例如分别为((III)或euro(III)/ ter(III))。多峰态镧系元素成像剂的设计,合成和表征。基于DO3A的一系列镧系螯合剂的合成是带有苯并咪唑或苄基衍生物的,它们既可以作为生色团单元,也可以作为偶联的连接基团,具有偶联至光学染料的功能(若丹明或BODIPY衍生物)制备了一系列与硝基或氨基苄基苯并咪唑DO3A螯合剂或与氨基苄基DO3A螯合剂的镧系元素络合物。已经尝试了多种策略将络合物与光学染料偶联以形成多峰成像剂。研究了镧系元素络合物的物理性质和细胞摄取。结果表明,苯并咪唑配体可以敏化the(III)和ter(III)金属离子的发光。 n(III)苯并咪唑DOS A复合物的弛豫速率与市售造影剂相当。与配体1,4,7-三(羧甲基)-10-(1-(4-硝基苄基)-2-甲基苯并咪唑)-1,4,7,10-四氮杂环十二烷形成的ado(III)配合物的弛豫性(34)为6.22 mM“ 1 s” 1,with与(1,4,7-三(羧甲基)-10-(1-(4-氨基苄基)-2-甲基苯并咪唑)形成的((III)配合物的弛豫性发现)-1,4,7,10-四氮杂环十二烷(37)在4.51 mM“ 1 s” 1处较低。 and和D2O中的((III)和ter(III)配合物的发光寿命用于计算水溶液中配位水分子的数量[对于(34)的complex(III)配合物,q = 1.19,0.7-0.8 (37)的((III)配合物和(34)的b(III)配合物1.25]

著录项

  • 作者

    Sparke Amanda E.;

  • 作者单位
  • 年度 2008
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号